Month: July 2015

Blue Horseshoe Stocks: Fresh Options Ideas & More

Pazoo Inc. PZOO

PZOO has been progressing well in the past several sessions since we last touched base with the stock a couple of weeks ago. We had just received word from the company that its wholly-owned CannabisKing Distribution subsidiary had struck two significant deals (Links to PR’s below), and witnessed a two-session swing of 74% as a result.

After regrouping and bouncing off of a low of .0046 (07/13), PZOO has made continuously higher lows for the rest of this month, and pushed its PPS back to the current range (.006-.007). We’ve provided the following snapshot illustrating the current bullish characteristics of the chart.

We’ll be on the lookout for further updates regarding the many irons PZOO currently has in the fire, and you can be sure that we’ll pass them along as the stories develop.

Fresh Options Ideas

As we approach midweek with earnings drops in full swing, we’re going to formulate a few corresponding options ideas we feel have the potential to perform well:

Ford Motor Co. (F) – Ford set record North American profits and beat Wall St. expectations handily this morning. The stock is gapping up moderately, so we’re going to taking a look at F Weekly $14.50 and $15 Calls, which should produce some nice action.

Pfizer, Inc. PFE –  Pfizer also had an earnings beat on their Q2 release today, and our related options ideas will be to monitor PFE Weekly $34.50 and $35 Calls.

Baidu, Inc. BIDU – After an extreme analyst downgrade, BIDU is taking an absolute beating, and is leading us to include a rare idea on the bearish side of things; we’ll be tracking BIDU Weekly Puts in the $180-175 Range.

Cytori Therapeutics, Inc. CYTX

We also want to raise a flag on a familiar stock cropping up in the news feed this morning. Early this year we saw CYTX make a huge move, and after spending the last several months in a general downtrend, some FDA-related news out this morning could be just the thing to catalyze a reversal. We’ll be watching intently for that possibility; check out the news below.

Cytori Therapeutics, Inc. (CYTX) today announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia). >> FULL PR

Extended Watchlist:
PGNX, SDRL, NYMX, AKS, RJET

Blue Horseshoe Stocks: CRGP, Options Recaps & More

Calissio Resources Group, Inc. CRGP

First up this morning is a stock that we called in Friday’s extended watchlist The volatility in CRGP was an excellent target for flippers on Friday, with the stock coming out with a nice initial intraday run before following it up with a couple of subsequent bounces.

It began from a morning low of .0043 from which point CRGP rattled off its first swing up to the high-of-day at .0067; a nice 56% surge. After pulling back to .0045, it ran promptly back to .006 adding another 33% pop. It finished up with a dip back to .005 and 20% run-back to .006.

In total, CRGP’s session produced cumulative gains on the order of 109%, fueled by the news that the company had completed a $14.6M sale of its Mexican copper mine >> READ PR

Inotek Pharmaceutical Corp. ITEK

We tagged ITEK in Thursday’s premarket report, after noticing some FDA-related news hitting the wires, and during that session we would witness a low of 7.66 before the stock took off on an impressive tear that bled into Friday’s trading as well.

On Friday, the momentum carried the stock to a new high of 19.45, which registered as an overnight increase of 154%, so we want to send our congratulations to those of our readers who caught our report and cashed in on that impressive move!

Friday’s Winning Options Ideas

The big winners among the options ideas that we submitted in Friday morning’s report turned out to be the FB Weekly $96-50-97.50 Calls . Every one of the contracts in the range we specified turned up chances at impressive profits. Here’s a breakdown of the gains that were made possible by our timely alert.

The $96.50 Calls came out of the gate with a nice initial 108% move of from .65-1.35. That was followed up by a significant pullback to its daily low of .07 before running hard back to .58; an incredible 728% surge.

The $97 Calls produced similar action, with their first run taking them from .37-.96 (+159%), followed by a dip back to a penny before reaching back to a dime. That second move, like the previously mentioned contracts, was far more pronounced, coming in at a whopping  900%

The 97.50’s did make a move from .22-.52, an intraday gain of 136%, however they ended up too far out of the money to see a second run like the aforementioned plays. Still, their performance was nothing to sneeze at; any way you slice it, our FB Options ideas from Friday were a huge success!

Extended Watchlist:
MNOV (FDA Approval News), OGXI, XUE, SVLC, GDP, PSTI, VLTC

Blue Horseshoe Stocks: ITEK Recap, Options Ideas & More

Inotek Pharmaceutical Corp. ITEK

Our report for yesterday brought a couple of nice opportunities, with ITEK standing out as the most impressive. We caught this play on our routine morning scan, after noticing some abnormally elevated premarket activity. The company had released some information regarding its glaucoma treatment exiting Phase II studies and laying a strategic path for Phase III, and needless to say, it was very well-received.

This wasn’t a blink-and-you’ll-miss-it sort of move either, with just a small move up to start the session, ITEK traded sideways for most of the morning. Just prior to lunchtime is when we started to see the beginnings of an epic intraday run, especially for a stock in this price range.

From a low of  7.66, the stock exploded to reach a daily (and new annual) high of 16.75, standing as a single-session surge of 119%  The overall move as of this morning’s premarket high of 18.20 registers as an overnight increase of 138%  Cheers go out to any of our readers who caught our alert!

Inotek Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA and Phase 3 Development Strategy for Trabodenoson, a Novel Treatment for Glaucoma (Thu, Jul 23)

WindStream Technologies, Inc. WSTI

It was Tuesday’s Letter to Shareholders that caught our eye in the premarket news feed, causing us to raise a flag on WSTI that morning.

We’ve covered it every day since, and have been rewarded with incremental gains throughout, with the stock recording higher highs and higher lows each session. Yesterday, we witnessed an intraday run from .0172-.0244, which yielded the chance at gains of up to 42% on the day.

From our observed low on Tuesday (the 52-week low of .0085) we’ve now seen an overall jump in WSTI amounting to 187% in just three session’s time. Refer to the annotated chart below to evaluate WSTI’s chances of making further advances from this juncture.

Friday Options Ideas

If you recall last Friday, we came up huge with an alert on Weekly GOOG Calls.  We mentioned how time-decay at this point in the week begins to evaporate premiums in contracts with a weekly expiration, and generates a high-octane volatile environment where big gains are often there for the taking for those who can assume a higher-than-average risk.  A 694% intraday run from one of the sets of contracts we highlighted in that report was there to prove our point.

___

We’re going to venture a similar set of ideas this morning for Weekly AMZN Calls in the $575-595 range. The stock is gapping up hard this morning to the tune of 20%, thus we will have our eyes peeled for a classic dip-and-rip scenario.

___

We’re also going to put a marker flag on Weekly FB Calls from $96-50-97.50. The stock is rebounding off of a pullback over the past couple of days, after performing extremely well for the majority of this month.

Extended Watchlist:
AMDA, ACRX, CALA, ICLD, CRGP(news), HERO(52-wk lows)